Search research articles
Contact Us
Filters
Showing results (231-240 of 272) with videos related to
Page
of 28
Sort By:
Clinical Pharmacology and Therapeutics
|
July 1, 1977
Enhancement of hydralazine bioavailability by food
A Melander, K Danielson, A Hanson, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Large intercommunity difference in cardiovascular drug consumption: relation to mortality, risk factors and socioeconomic differences
M Oreberg, G G Jonsson, K West, et al.
Diabetologia
|
June 16, 2000
Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study
J Olsson, G Lindberg, M Gottsäter, et al.
Diabetes Care
|
October 1, 1994
Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study
L S Hermann, B Scherstén, P O Bitzén, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol
B Hallengren, O R Nilsson, B E Karlberg, et al.
Scandinavian Journal of Rheumatology
|
January 1, 1981
Comparison of diflunisal and acetylsalicylic acid in patients with rheumatoid arthritis
L Lindholm, C Ekdahl, E Håkansson, et al.
European Journal of Clinical Pharmacology
|
January 1, 1990
Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe
G Dukes, P K Lunde, A Melander, et al.
Acta Medica Scandinavica
|
January 1, 1977
Effects of total energy withdrawal (fasting) on thelevels of growth hormone, thyrotropin, cortisol, adrenaline, noradrenaline, T4, T3, and rT3 in healthy males
J Palmblad, L Levi, A Burger, et al.
BMJ (Clinical Research Ed.)
|
August 25, 2001
Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study
J Merlo, H Liedholm, U Lindblad, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1994
Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period
D Worm, J E Henriksen, A Vaag, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 272) with videos related to
Sort By:
Page
of 28
Clinical Pharmacology and Therapeutics
|
July 1, 1977
Enhancement of hydralazine bioavailability by food
A Melander, K Danielson, A Hanson, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Large intercommunity difference in cardiovascular drug consumption: relation to mortality, risk factors and socioeconomic differences
M Oreberg, G G Jonsson, K West, et al.
Diabetologia
|
June 16, 2000
Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study
J Olsson, G Lindberg, M Gottsäter, et al.
Diabetes Care
|
October 1, 1994
Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study
L S Hermann, B Scherstén, P O Bitzén, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol
B Hallengren, O R Nilsson, B E Karlberg, et al.
Scandinavian Journal of Rheumatology
|
January 1, 1981
Comparison of diflunisal and acetylsalicylic acid in patients with rheumatoid arthritis
L Lindholm, C Ekdahl, E Håkansson, et al.
European Journal of Clinical Pharmacology
|
January 1, 1990
Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe
G Dukes, P K Lunde, A Melander, et al.
Acta Medica Scandinavica
|
January 1, 1977
Effects of total energy withdrawal (fasting) on thelevels of growth hormone, thyrotropin, cortisol, adrenaline, noradrenaline, T4, T3, and rT3 in healthy males
J Palmblad, L Levi, A Burger, et al.
BMJ (Clinical Research Ed.)
|
August 25, 2001
Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study
J Merlo, H Liedholm, U Lindblad, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1994
Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period
D Worm, J E Henriksen, A Vaag, et al.
Page
of 28